新しい疼痛制御分子「リン脂質生合成酵素」を標的にしたドラッグリポジショニング研究

• Project/Area Number: 21K15309
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 47060:Clinical pharmacy-related
• Research Institution: National Center for Global Health and Medicine
• Principal Investigator: 山本 将大 国立研究開発法人国立国際医療研究センター, その他部局等, その他 (50825693)
• Project Period (FY): 2021-04-01 – 2023-03-31
• Project Status: Adopted (Fiscal Year 2021)
• Budget Amount: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000); Fiscal Year 2022: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000); Fiscal Year 2021: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)